{"id":10737,"date":"2026-02-25T23:02:25","date_gmt":"2026-02-25T23:02:25","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2026\/02\/25\/biotech-news-novo-doubles-down-on-oral-peptides\/"},"modified":"2026-02-25T23:02:25","modified_gmt":"2026-02-25T23:02:25","slug":"biotech-news-novo-doubles-down-on-oral-peptides","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2026\/02\/25\/biotech-news-novo-doubles-down-on-oral-peptides\/","title":{"rendered":"STAT+: Novo doubles down on oral peptides"},"content":{"rendered":"<p>    STAT+: Novo doubles down on oral peptides<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p><em>Want to stay on top of the science and politics driving biotech today?\u00a0<a href=\"https:\/\/www.statnews.com\/signup\/readout\/\">Sign up<\/a>\u00a0to get our biotech newsletter in your inbox.<\/em><\/p>\n<p>Good morning. By the time this newsletter sends, I\u2019ll be on a plane headed towards vacation. See you next week!<\/p>\n<h2 class=\"wp-block-heading\" id=\"h-the-need-to-know-this-morning\">The need-to-know this morning<\/h2>\n<ul class=\"wp-block-list\">\n<li>\n<strong>Alkermes<\/strong> CEO Richard Pops is <a href=\"https:\/\/investor.alkermes.com\/news-releases\/news-release-details\/alkermes-plc-announces-ceo-succession-plan\" rel=\"noopener\">retiring this summer<\/a>, ending a 35-year run at the top of the neuroscience company. Blair Jackson, Alkermes\u2019 current chief operating officer, will assume the CEO role.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\" id=\"h-gsk-acquires-nbsp-pulmonary-hypertension-drug\">GSK acquires\u00a0pulmonary hypertension drug<\/h2>\n<p>The <a href=\"https:\/\/www.statnews.com\/2026\/02\/25\/gsk-acquires-35pharma-pulmonary-hypertension\/\" rel=\"noopener\">deal<\/a> for privately held 35Pharma is small, just under $1 billion in cash, but it adds an experimental treatment for pulmonary arterial hypertension to GSK\u2019s research pipeline and bolsters its recent shift towards respiratory and immunology medicines.<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2026\/02\/25\/biotech-news-novo-doubles-down-on-oral-peptides\/?utm_campaign=rss\">Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Elaine Chen<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2026\/02\/25\/biotech-news-novo-doubles-down-on-oral-peptides\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STAT+: Novo doubles down on oral peptides Want to stay on top of the science and politics driving biotech today?\u00a0Sign up\u00a0to get our biotech newsletter in your inbox. Good morning. By the time this newsletter sends, I\u2019ll be on a plane headed towards vacation. See you next week! The need-to-know this morning Alkermes CEO Richard [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2154,58,2208,2209,2176,858,2207],"tags":[2150],"class_list":["post-10737","post","type-post","status-publish","format-standard","hentry","category-biotech","category-biotechnology","category-business","category-drug-development","category-drug-prices","category-pharma","category-research","category-the-readout","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/10737"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=10737"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/10737\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=10737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=10737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=10737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}